JUNIPER PHARMACEUTICALS INC Additional Paid in Capital
JUNIPER PHARMACEUTICALS INC had Additional Paid in Capital of $294.58 million as of 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2018-08-09
- 2018-06-30: Additional Paid in Capital $294.58M.
- 2018-03-31: Additional Paid in Capital $294.06M.
- 2017-12-31: Additional Paid in Capital $292.11M.
- 2017-09-30: Additional Paid in Capital $291.86M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2018-06-30 | $294.58M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $294.06M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $292.11M 10-Q · filed 2018-08-09 | |
| 2017-09-30 | $291.86M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $291.47M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $290.97M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $290.64M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $290.25M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $289.93M 10-Q/A · filed 2016-11-14 | |
| 2016-03-31 | $289.57M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $289.46M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $289.12M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $288.63M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $288.19M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $287.66M 10-K/A · filed 2016-11-14 | |
| 2014-09-30 | $287.50M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $287.40M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $287.22M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $287.05M 10-K · filed 2015-03-18 | $287.05M 10-K · filed 2014-03-05 |
| 2013-09-30 | $287.89M 10-Q/A · filed 2014-03-03 | |
| 2013-06-30 | $278.95M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $278.80M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $279.46M 10-K · filed 2014-03-05 | $278.70M 10-K · filed 2013-03-14 |
| 2012-09-30 | $278.70M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $278.53M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $278.37M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $278.06M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $277.90M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $277.77M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $260.60M 10-K · filed 2012-03-12 |